Early-Stage Funding Gap Targeted By Two New U.K. Funds, Deepbridge Innovation Fund And Target Development Fund
This article was originally published in The Pink Sheet Daily
Executive Summary
Deepbridge Capital aims to raise £250 million to support early-stage research, recruits ex-GSK CEO Sykes to chair investment committee.